Commentary

Consider this probiotic for functional abdominal pain


 

References

In the article, “When can infants and children benefit from probiotics?” (J Fam Pract. 2016;65:789-794), Dassow et al recommended probiotics as a therapeutic tool for reducing abdominal pain associated with pediatric irritable bowel syndrome (IBS). There are several types of functional disorders in childhood with related abdominal pain, the most common of which are IBS and functional abdominal pain (FAP).1,2

Several recent randomized placebo-controlled trials—one of which I led—have shown that Lactobacillus reuteri DSM 17938 is a beneficial treatment for FAP in children.3-5 When compared with placebo, this probiotic agent significantly reduced the frequency and intensity of FAP in children.

Family physicians should consider this probiotic microorganism as a potential therapeutic tool for IBS, as well as childhood FAP.

Zvi Weizman, MD
Beer-Sheva, Israel

Recommended Reading

Risks of keeping controlled substances in office tilt away from benefits
MDedge Family Medicine
AHRQ identifies interventions, drugs that best target diabetic neuropathy
MDedge Family Medicine
Poll: How have you changed opioid prescribing in your practice?
MDedge Family Medicine
Knee OA structural defects predict pain trajectories
MDedge Family Medicine
For opioid-related hospitalizations, men and women are equal
MDedge Family Medicine
Novel ibuprofen formulation cuts GI side effects in patients with knee pain flares
MDedge Family Medicine
Follow five tips to mitigate opioid prescribing risks
MDedge Family Medicine
The latest news on pediatric migraine
MDedge Family Medicine
Knee bone density improved in osteoarthritis with load-reducing shoe
MDedge Family Medicine
‘Chronic Lyme’: Serious bacterial infections reported with unproven treatments
MDedge Family Medicine

Related Articles